Gastric cancer--the recognition of a chemosensitive tumour.
作者信息
Cunningham D
机构信息
Ludwig Institute for Cancer Research, St. Mary's Hospital Medical School, London, UK.
出版信息
Br J Cancer. 1988 Dec;58(6):695-9. doi: 10.1038/bjc.1988.292.
Abstract
摘要
相似文献
1
Gastric cancer--the recognition of a chemosensitive tumour.胃癌——一种对化疗敏感的肿瘤的认识。
Br J Cancer. 1988 Dec;58(6):695-9. doi: 10.1038/bjc.1988.292.
2
[Chemotherapy of gastric adenocarcinoma].[胃腺癌的化疗]
Srp Arh Celok Lek. 2000 Nov-Dec;128(11-12):409-12.
3
Pre- and postoperative chemotherapy for resectable gastric adenocarcinoma.可切除胃腺癌的术前和术后化疗。
Ann R Coll Surg Engl. 1998 Jan;80(1):73.
4
The role of systemic therapy for localised gastric cancer.全身治疗在局限性胃癌中的作用。
Ann Oncol. 2006 Sep;17 Suppl 10:x115-21. doi: 10.1093/annonc/mdl248.
5
Gastric cancer--new therapeutic options.胃癌——新的治疗选择。
N Engl J Med. 2006 Jul 6;355(1):76-7. doi: 10.1056/NEJMe068121.
6
Adjuvant treatment for gastric cancer: too much is not enough.胃癌辅助治疗：过犹不及。
Lancet Oncol. 2014 Jul;15(8):788-9. doi: 10.1016/S1470-2045(14)70293-1. Epub 2014 Jun 18.
7
Ag NORs in evaluation of neo-adjuvant chemotherapy for gastric adenocarcinoma.银染核仁组织区在胃腺癌新辅助化疗评估中的应用
Eur J Surg Oncol. 1990 Oct;16(5):468.
8
Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma.采用FOLFOX方案辅助化疗治疗胃肝样腺癌。
Dig Liver Dis. 2014 Dec;46(12):1135-6. doi: 10.1016/j.dld.2014.08.036. Epub 2014 Aug 30.
9
[Efficacy of chemotherapy and combined chemo-radiotherapy in gastric adenocarcinoma].[化疗及化疗联合放疗在胃腺癌中的疗效]
Bull Cancer. 1989;76(9):1007-20.
10
Targeted therapy for gastric cancer.胃癌的靶向治疗
Lancet Oncol. 2013 May;14(6):440-2. doi: 10.1016/S1470-2045(13)70133-5. Epub 2013 Apr 15.
引用本文的文献
1
Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis.前列腺干细胞抗原（PSCA）的下调促进胃癌增殖并与不良预后相关。
J Cancer. 2020 Feb 19;11(9):2708-2715. doi: 10.7150/jca.33575. eCollection 2020.
2
Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein.胃癌多药耐药的组织病理学评估：P-糖蛋白、多药耐药相关蛋白和肺耐药蛋白的表达
Surg Today. 1999;29(5):401-6. doi: 10.1007/BF02483030.
本文引用的文献
1
Carcinoma of the stomach.胃癌
Br Med J. 1952 Feb 9;1(4753):287-92. doi: 10.1136/bmj.1.4753.287.
2
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.5-氟尿嘧啶、多柔比星和丝裂霉素（FAM）联合化疗用于晚期胃癌
Ann Intern Med. 1980 Oct;93(4):533-6. doi: 10.7326/0003-4819-93-4-533.
3
4
Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.
Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):1-11. doi: 10.1016/0360-3016(82)90377-7.
5
Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group.胃癌根治性切除术后辅助化疗的对照试验。胃肠道肿瘤研究组。
Cancer. 1982 Mar 15;49(6):1116-22. doi: 10.1002/1097-0142(19820315)49:6<1116::aid-cncr2820490609>3.0.co;2-u.
6
Studies in prognostic factors relating to chemotherapy for advanced gastric cancer.晚期胃癌化疗相关预后因素的研究。
Cancer. 1982 Nov 15;50(10):2016-23. doi: 10.1002/1097-0142(19821115)50:10<2016::aid-cncr2820501007>3.0.co;2-2.
7
Confirmed activity of FAM polychemotherapy in advanced gastric carcinoma.证实FAM联合化疗在晚期胃癌中的活性。
Tumori. 1983 Feb 28;69(1):59-64. doi: 10.1177/030089168306900110.
8
A phase II study of cisplatin in advanced gastric cancer.顺铂用于晚期胃癌的II期研究。
Eur J Cancer Clin Oncol. 1983 Jun;19(6):717-20. doi: 10.1016/0277-5379(83)90003-2.
9
Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.进展期胃癌：苏格兰使用氟尿嘧啶、阿霉素和丝裂霉素-C的经验。
Br J Surg. 1984 Sep;71(9):673-6. doi: 10.1002/bjs.1800710909.
10
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).司莫司汀（甲环亚硝脲）辅助治疗胃肠道癌后的白血病和白血病前期
N Engl J Med. 1983 Nov 3;309(18):1079-84. doi: 10.1056/NEJM198311033091802.
Zotero 插件